ZA201701772B - Pharmaceutical formulation for reducing bladder spasms and method of use thereof - Google Patents

Pharmaceutical formulation for reducing bladder spasms and method of use thereof

Info

Publication number
ZA201701772B
ZA201701772B ZA2017/01772A ZA201701772A ZA201701772B ZA 201701772 B ZA201701772 B ZA 201701772B ZA 2017/01772 A ZA2017/01772 A ZA 2017/01772A ZA 201701772 A ZA201701772 A ZA 201701772A ZA 201701772 B ZA201701772 B ZA 201701772B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical formulation
bladder spasms
reducing bladder
reducing
spasms
Prior art date
Application number
ZA2017/01772A
Other languages
English (en)
Inventor
A Dill David
Original Assignee
Wellesley Pharmaceuticals Llc A Llc Organised And Existing Under The Laws Of The State Of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellesley Pharmaceuticals Llc A Llc Organised And Existing Under The Laws Of The State Of Delaware filed Critical Wellesley Pharmaceuticals Llc A Llc Organised And Existing Under The Laws Of The State Of Delaware
Publication of ZA201701772B publication Critical patent/ZA201701772B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/06Anti-spasmodics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2017/01772A 2014-09-24 2017-03-10 Pharmaceutical formulation for reducing bladder spasms and method of use thereof ZA201701772B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/057200 WO2016048301A1 (en) 2014-09-24 2014-09-24 Pharmaceutical formulation for reducing bladder spasms and method of use thereof

Publications (1)

Publication Number Publication Date
ZA201701772B true ZA201701772B (en) 2018-08-29

Family

ID=55581626

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2017/01772A ZA201701772B (en) 2014-09-24 2017-03-10 Pharmaceutical formulation for reducing bladder spasms and method of use thereof

Country Status (13)

Country Link
EP (1) EP3197441A4 (ko)
JP (1) JP2017532301A (ko)
KR (1) KR20170049613A (ko)
CN (1) CN107072971A (ko)
AU (1) AU2014407186A1 (ko)
BR (1) BR112017006141A2 (ko)
CA (1) CA2962004A1 (ko)
IL (1) IL250827A0 (ko)
MX (1) MX2017003878A (ko)
RU (1) RU2017113827A (ko)
SG (1) SG11201702069XA (ko)
WO (1) WO2016048301A1 (ko)
ZA (1) ZA201701772B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7025129B2 (ja) * 2017-05-17 2022-02-24 小林製薬株式会社 筋痙攣治療剤
WO2019240755A1 (en) * 2018-06-11 2019-12-19 Wellesley Pharmaceuticals, Llc Pharmaceutical compositions and methods for weight loss

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0328060D0 (en) * 2003-12-04 2004-01-07 Sod Conseils Rech Applic Botulinum toxin treatment
MX2007014496A (es) * 2005-05-20 2008-02-11 Omeros Corp Composiciones de inhibidor de ciclooxigenasa y antagonista de los canales de calcio y metodos para usarlas en procedimientos urologicos.
CN101460150B (zh) * 2006-03-31 2014-02-12 鲁比康研究私人有限公司 用于口腔崩解片剂的可直接压片复合物
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method
US20120010294A1 (en) * 2010-07-08 2012-01-12 Dill David A Compositions and methods for the inhibition of muscle contraction
AU2012211960B2 (en) * 2011-02-04 2016-12-01 Taris Biomedical Llc Implantable device for controlled release of low solubility drug
MY173582A (en) * 2012-01-04 2020-02-04 Wellesley Pharmaceuticals Llc Extended-release formulation for reducing the frequency of urination and method of use thereof
CN103191430A (zh) * 2012-01-04 2013-07-10 韦尔斯利医药有限公司 用于缓解尿频的缓释制剂及其使用方法

Also Published As

Publication number Publication date
CN107072971A (zh) 2017-08-18
CA2962004A1 (en) 2016-03-31
RU2017113827A (ru) 2018-10-24
JP2017532301A (ja) 2017-11-02
AU2014407186A1 (en) 2017-03-09
IL250827A0 (en) 2017-04-30
WO2016048301A1 (en) 2016-03-31
KR20170049613A (ko) 2017-05-10
BR112017006141A2 (en) 2018-02-06
MX2017003878A (es) 2017-06-28
EP3197441A1 (en) 2017-08-02
EP3197441A4 (en) 2018-05-23
RU2017113827A3 (ko) 2018-10-24
SG11201702069XA (en) 2017-04-27

Similar Documents

Publication Publication Date Title
IL250496A0 (en) A device that includes an expandable body and a method of use
IL252172B (en) Expandable drug delivery devices and methods of use
SG11201609966SA (en) Drug delivery system and method of use
PT3104814T (pt) Aparelho para administração supra-coroidal de agente terapêutico
IL251246A0 (en) Therapeutically active compounds and methods of use
IL252199A0 (en) Spray drying device and method of use
IL248060A0 (en) System and method for therapeutic management of cough
GB201514760D0 (en) Compounds and method of use
GB201421197D0 (en) Apparatus and method of use thereof
EP3194377A4 (en) Heterocycle substituted amino-pyridine compounds and methods of use thereof
IL249348A0 (en) A new preparation and method for synthesis
EP3152281A4 (en) Defoaming agent and associated methods of use
SG11201605915WA (en) Furo-3-carboxamide derivatives and methods of use
GB2548269B (en) Exercise system and method of use thereof
SG11201610383YA (en) Pharmaceutical formulation for reducing frequency of urination and method of use thereof
ZA201701772B (en) Pharmaceutical formulation for reducing bladder spasms and method of use thereof
IL248035A0 (en) Database and the method of using it
GB201408171D0 (en) Formulation and method of manufacture
EP3197779A4 (en) Danger avoidance apparatus and method of use
GB201517613D0 (en) Scaffolding apparatus and method of use thereof
EP3143000A4 (en) Dosage of dasotraline and method for treatment of adhd
AU2014905266A0 (en) Formulation and method of use
GB201416797D0 (en) Contianer and method of use thereof
GB201403200D0 (en) Cushion means and method of use thereof
GB201408738D0 (en) Components and methods for formulation of components